Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells

doi:10.1084/jem.174.1.1

This Article

	Full Text (PDF, 766K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Dougherty, G. J.
	Articles by Humphries, R. K.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Dougherty, G. J.
	Articles by Humphries, R. K.


Social Bookmarking

	What's this?

ARTICLES

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells

GJ Dougherty, PM Landorp, DL Cooper and RK Humphries
Terry Fox Laboratory for Hematology/Oncology, British Columbia Cancer Research Centre, Vancouver, Canada.

In addition to the 85-95 kD CD44 species found on most hemopoietic cell types, the human myelomonocytic cell line KG1a expresses proteins of approximately 115 kD and 130 kD that react with monoclonal antibodies belonging to CD44. The possibility that these higher molecular weight species may represent novel CD44 isoforms containing additional protein sequence was investigated. CD44 cDNA clones were isolated from a plasmid-based expression library prepared from KG1a mRNA. One of the three clones obtained (clone 2.3) was found to encode a CD44 molecule of approximately 130 kD in transfected COS cells. Sequences analysis indicated that the molecule encoded by this cDNA clone, designated CD44R1, was essentially identical to CD44 except for the presence of an additional 132 amino acids inserted into the extracellular domain. This inserted region is rich in serine and threonine residues that may serve as sites of O-linked glycosylation, and contains a potential site of N- linked glycosylation and a potential site of chondroitin sulphate attachment. PCR analysis using primers that flank the inserted region present within CD44R1 identified an additional CD44 isoform, designated CD44R2, that contains only the last 69 amino acids present within the unique region of CD44R1. Peripheral blood mononuclear cells and granulocytes from normal individuals and patients with chronic myelogenous leukemia, polycythemia vera, or acute myelomonocytic leukemia, express both CD44R1 and CD44R2. In contrast, CD44R1 and CD44R2 appear to be differentially expressed in various CD44-positive cell lines. Thus KG1a, and the Epstein-Barr Virus-transformed B cell lines WalkDR4 and Way-1 express both CD44 and the CD44 isoforms CD44R1 and CD44R2, while the myeloid cell lines HL60 and U937 express high levels of CD44, but only very low levels of CD44R1 and CD44R2. The CD44- negative cell lines DHL-4, DHL-10, Jurkat, and K562 are also negative for CD44R1 and CD44R2.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Ruffell, B., Johnson, P. (2008). Hyaluronan Induces Cell Death in Activated T Cells through CD44. J. Immunol. 181: 7044-7054 [Abstract] [Full Text]
Rouschop, K. M.A., Claessen, N., Pals, S. T., Weening, J. J., Florquin, S. (2006). CD44 Disruption Prevents Degeneration of the Capillary Network in Obstructive Nephropathy via Reduction of TGF-beta1-Induced Apoptosis. J. Am. Soc. Nephrol. 17: 746-753 [Abstract] [Full Text]
Rouschop, K. M. A., Roelofs, J. J.T.H., Claessen, N., Martins, P. d. C., Zwaginga, J.-J., Pals, S. T., Weening, J. J., Florquin, S. (2005). Protection against Renal Ischemia Reperfusion Injury by CD44 Disruption. J. Am. Soc. Nephrol. 16: 2034-2043 [Abstract] [Full Text]
Rouschop, K. M.A., Sewnath, M. E., Claessen, N., Roelofs, J. J.T.H., Hoedemaeker, I., van der Neut, R., Aten, J., Pals, S. T., Weening, J. J., Florquin, S. (2004). CD44 Deficiency Increases Tubular Damage But Reduces Renal Fibrosis in Obstructive Nephropathy. J. Am. Soc. Nephrol. 15: 674-686 [Abstract] [Full Text]
Gee, K., Kozlowski, M., Kumar, A. (2003). Tumor Necrosis Factor-{alpha} Induces Functionally Active Hyaluronan-adhesive CD44 by Activating Sialidase through p38 Mitogen-activated Protein Kinase in Lipopolysaccharide-stimulated Human Monocytic Cells. J. Biol. Chem. 278: 37275-37287 [Abstract] [Full Text]
Hayes, G. M., Chiu, R., Carpenito, C., Dougherty, S. T., Dougherty, G. J. (2002). Identification of Sequence Motifs Responsible for the Adhesive Interaction between Exon v10-containing CD44 Isoforms. J. Biol. Chem. 277: 50529-50534 [Abstract] [Full Text]
Xu, H., Ito, T., Tawada, A., Maeda, H., Yamanokuchi, H., Isahara, K., Yoshida, K., Uchiyama, Y., Asari, A. (2002). Effect of Hyaluronan Oligosaccharides on the Expression of Heat Shock Protein 72. J. Biol. Chem. 277: 17308-17314 [Abstract] [Full Text]
van der Voort, R., Taher, T. E.�I., Wielenga, V. J.�M., Spaargaren, M., Prevo, R., Smit, L., David, G., Hartmann, G., Gherardi, E., Pals, S. T. (1999). Heparan Sulfate-modified CD44 Promotes Hepatocyte Growth Factor/Scatter Factor-induced Signal Transduction through the Receptor Tyrosine Kinase c-Met. J. Biol. Chem. 274: 6499-6506 [Abstract] [Full Text]
Rachmilewitz, J., Tykocinski, M. L. (1998). Differential Effects of Chondroitin Sulfates A and B on Monocyte and B-Cell Activation: Evidence for B-Cell Activation Via a CD44-Dependent Pathway. Blood 92: 223-229 [Abstract] [Full Text]
Zoller, M., Schmidt, A., Denzel, A., Moll, J. (1997). Constitutive Expression of a CD44 Variant Isoform on T Cells Facilitates Regaining of Immunocompetence in Allogeneic Bone Marrow Transplantation. Blood 90: 873-885 [Abstract] [Full Text]
Wood, N.W., Sawcer, S.J., Kellar-Wood, H.F., Holmans, P., Clayton, D., Robertson, N., Compston, D.A.S. (1995). The T-cell receptor beta locus and susceptibility to multiple sclerosis. Neurology 45: 1859-1863 [Abstract] [Full Text]
Brosnan, C. F., Cannella, B., Battistini, L., Raine, C. S. (1995). Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species. Neurology 45: S16-S21 [Abstract] [Full Text]
Burger, D., Dayer, J.-M. (1995). Inhibitory cytokines and cytokine inhibitors. Neurology 45: S39-S43 [Abstract] [Full Text]
Perschl, A, Lesley, J, English, N, Hyman, R, Trowbridge, I. (1995). Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J. Cell Sci. 108: 1033-1041 [Abstract]
Matsumura, Y, Hanbury, D, Smith, J, Tarin, D (1994). Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 308: 619-624 [Abstract] [Full Text]
Milstone, L., Hough-Monroe, L, Kugelman, L., Bender, J., Haggerty, J. (1994). Epican, a heparan/chondroitin sulfate proteoglycan form of CD44, mediates cell-cell adhesion. J. Cell Sci. 107: 3183-3190 [Abstract]
Wheatley, S., Isacke, C., Crossley, P. (1993). Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation and patterning. Development 119: 295-306 [Abstract]
Kennel, S., Lankford, T., Foote, L., Shinpock, S., Stringer, C (1993). CD44 expression on murine tissues. J. Cell Sci. 104: 373-382 [Abstract]
Underhill, C. (1992). CD44: the hyaluronan receptor. J. Cell Sci. 103: 293-298
Dimitroff, C. J., Lee, J. Y., Fuhlbrigge, R. C., Sackstein, R. (2000). A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc. Natl. Acad. Sci. USA 97: 13841-13846 [Abstract] [Full Text]